CHAMBERS v. COMMISSIONER OF SOCIAL SECURITY

CourtDistrict Court, D. New Jersey
DecidedOctober 18, 2022
Docket3:21-cv-20678
StatusUnknown

This text of CHAMBERS v. COMMISSIONER OF SOCIAL SECURITY (CHAMBERS v. COMMISSIONER OF SOCIAL SECURITY) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CHAMBERS v. COMMISSIONER OF SOCIAL SECURITY, (D.N.J. 2022).

Opinion

*NOT FOR PUBLICATION*

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

RAMONA CHAMBERS,

Plaintiff, Civil Action No. 21-20678 (FLW) v. OPINION KILOLO KIJAKAZI, Acting Commissioner of Social Security,

Defendant.

WOLFSON, Chief Judge:

Ramona Chambers (“Plaintiff”) appeals from the final decision of the Acting Commissioner of Social Security, Kilolo Kijakazi (“Defendant”), denying Plaintiff’s application for disability under Title II of the Social Security Act (the “Act”). After reviewing the Administrative Record (“A.R.”), the Court finds that the Administrative Law Judge (“ALJ”) failed to adequately consider the medical opinion of Plaintiff’s neuropsychologists with respect to Plaintiff’s cognitive abilities and limitations. Accordingly, the ALJ’s decision is REVERSED, and Plaintiff’s claim is REMANDED for further consideration consistent with the findings herein. I. FACTUAL AND PROCEDURAL HISTORY

Plaintiff, born on March 14, 1968, was 50 years old on her alleged disability onset date of June 25, 2018. (A.R. 32, 294.) Before the onset of her alleged disability, Plaintiff had worked as a middle school special education teacher for 18 years. (A.R. 299.) On May 20, 2019, Plaintiff filed a Title II application for a period of disability and disability insurance benefits, alleging disability due to non-Hodgkin’s lymphoma, cognitive disfunction from chemotherapy, lupus, and Sjogren’s syndrome. (A.R. 62, 298.) The application was denied initially on June 26, 2019, and upon reconsideration on August 12, 2019. (A.R. 75, 101–03.) Plaintiff then filed a written request for a hearing before an ALJ, which was held via video teleconference on April 30, 2021.

(A.R. 21, 41.) On June 14, 2021, the ALJ determined that Plaintiff was not disabled at any time from Plaintiff’s alleged disability onset date through the date of decision. (A.R. 33.) Following the ALJ’s decision, Plaintiff sought review by the Appeals Council, which was denied on October 19, 2021. (A.R. 1–7.) Plaintiff now appeals the ALJ’s decision under 42 U.S.C. § 405(g). A. Review of Medical Evidence

i. Medical Records The relevant period for Plaintiff’s disability claim runs from June 25, 2018 to June 14, 2021, the date of the ALJ’s decision denying disability insurance benefits. (A.R. 33–34.) Prior to that period, Plaintiff was diagnosed with and successfully treated for non-Hodgkin’s lymphoma. Plaintiff’s medical records indicate that she was treated for stage IV follicular lymphoma of the bone marrow in her thoracic spine with chemotherapy and radiation by physicians at Memorial Hospital for Cancer and Allied Diseases. (A.R. 431.) Following a mixed response to treatment with induction rituximab in 2016, on March 23, 2017, an MRI of Plaintiff’s spine showed the continued presence of lymphoma in vertebrae T9 and T10. (A.R. 460.) On March 24, 2017, Dr. Carla Hajj, M.D., recommended Plaintiff receive three cycles of R-CHOP chemotherapy followed by radiation. (A.R. 467.) Plaintiff received chemotherapy between March 2017 and May 2017. (A.R. 28, 475.) After a PET scan indicated disease improvement, Plaintiff also underwent consolidation radiation therapy between May 25, 2017 and June 19, 2017, which she tolerated well. (A.R. 475.) Treatment notes from immediately before and during the relevant period show that Plaintiff’s physical impairments were stable. On February 26, 2018, Dr. Charles B. Peeples, M.D., noted that Plaintiff’s cancer was “dormant.” (A.R. 883.) Likewise, on May 16, 2019, Dr.

Peeples stated that Plaintiff’s cancer was “in remission.” (A.R. 862.) During this time, Dr. Deborah Alpert described Plaintiff’s Sjogren’s syndrome as “stable” and “mild.” (A.R. 1051.) On October 23, 2019, Plaintiff received an MRI of her whole body, which was unremarkable. (A.R. 920.) Dr. Alpert’s progress notes from a February 8, 2021 appointment similarly indicate continued stability with respect to Plaintiff’s physical ailments. Based on that visit, Dr. Alpert noted that Plaintiff showed full range of motion of all joints, that Plaintiff’s Sjogren’s syndrome and lupus were both “stable,” and that there was no evidence of disease with respect to Plaintiff’s lymphoma. (A.R. 1262–64.) On December 12, 2017, Plaintiff presented to Memorial Hospital for Cancer and Allied Diseases for evaluation of memory loss. (A.R. 450.) Treatments notes indicate that Plaintiff did

not work as a math teacher between March 2017 and September 2017 due to fatigue associated with her lymphoma treatments. (Id.) Upon her return to work, Plaintiff experienced “difficulty with remembering numbers, medications, [and] days of the week.” (Id.) Plaintiff also reported being “forgetful” at home and “tell[ing] her husband the same thing multiple times.” (Id.) Although Dr. Anna Piotrowski, M.D., noted that Plaintiff’s “bedside neurological exam” was “benign,” Dr. Piotrowski ordered an MRI of Plaintiff’s brain and a lumbar puncture, among other things. (A.R. 452.) Dr. Piotrowski also noted “the possibility of neurotoxicity attributed to her chemotherapy” and recommended “neurocognitive testing.” (Id.) On January 26, 2018, Plaintiff reported for a follow-up appointment regarding her cognitive issues at which she was informed that imaging tests and bloodwork did not indicate lymphoma or “show reversible metabolic cause of memory loss.” (A.R. 456.) Dr. Piotrowski “recommended continued puzzles, active work, [and] socialization to prevent further memory decline.” (Id.)

On April 18, 2018, Plaintiff presented for neuropsychological consultation at Neuropsychology Rehabilitation Services – Lifespan Behavioral Health (“NRS”). (A.R. 421.) Following examination in July 2018, Dr. Mihir Shah, Psy.D., Dr. Robert B. Sica, Ph.D., and Dr. Steven P. Greco, Ph.D., issued a report, which stated that Plaintiff’s “neuropsychological findings reflected diffuse deficits consistent with cognitive dysfunction secondary to chemotherapy, an elevated psychological state and pre-existing, previously diagnosed [ADHD].” (A.R. 421–22.) Detailing their findings from the results of the Wechsler Adult Intelligence Scale, among other tests, the NRS team observed that Plaintiff’s attention and concentration were impaired, including slow processing speed, low average verbal reasoning, and impaired visual reasoning. (A.R. 423.) Additionally, Plaintiff’s “memory functioning . . . was one of her most salient impairments.” (Id.)

Plaintiff’s full-scale IQ score was 80, characterized as “low average reduced by approximately 1- standard deviation below her estimated baseline functioning.” (A.R. 422.) The NRS team further noted that “Psychologically, [Plaintiff’s] profile was consistent with an adjustment disorder with mixed emotions. Her clinical profile reflected mild-to-moderate elevation with health concerns, worry, anxiety, and difficulty thinking clearly.” (A.R. 425.) Recommendations included that Plaintiff “should apply for temporary disability and not return to work as a teacher” and that Plaintiff’s “cognitive and emotional status will be monitored to determine a return to work status.” (Id.) On August 13, 2018, Plaintiff began treatment at NRS to address and improve her decreased cognitive functioning. (A.R. 953.) Treatment notes from weekly sessions with Dr. Melissa Hillebrecht, Psy.D., indicate that Plaintiff’s cognitive performance at these sessions ranged from “limited” to “adequate” to “variable.” (A.R. 785–95.) During this same period, Dr. Peeples, Plaintiff’s primary care physician, noted that Plaintiff’s impaired concentration abilities

were “improving on medication.” (A.R. 869, 871.) On May 1, 2019, Drs. Sica, Greco, and Hillebrecht performed a repeat neuropsychological examination. (A.R.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bowen v. Yuckert
482 U.S. 137 (Supreme Court, 1987)
Brown v. Astrue
649 F.3d 193 (Third Circuit, 2011)
Warner-Lambert Company v. Breathasure, Inc.
204 F.3d 78 (Third Circuit, 2000)
Shirley McCrea v. Commissioner of Social Security
370 F.3d 357 (Third Circuit, 2004)
Mark Hagans v. Commissioner Social Security
694 F.3d 287 (Third Circuit, 2012)
Diaz v. Commissioner of Social Security
577 F.3d 500 (Third Circuit, 2009)
Simmonds v. Heckler
807 F.2d 54 (Third Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
CHAMBERS v. COMMISSIONER OF SOCIAL SECURITY, Counsel Stack Legal Research, https://law.counselstack.com/opinion/chambers-v-commissioner-of-social-security-njd-2022.